Characterization of V36C, a Novel Amino Acid Substitution Conferring Hepatitis C Virus (HCV) Resistance to Telaprevir, a Potent Peptidomimetic Inhibitor of HCV Protease

We characterized a novel substitution conferring moderate resistance to telaprevir, a peptidomimetic inhibitor of hepatitis C virus protease. V36C conferred a 4.0-fold increase in the telaprevir 50% inhibitory concentration in an enzyme assay and a 9.5-fold increase in the replicon model. The replic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Barbotte, Laetitia, Ahmed-Belkacem, Abdelhakim, Chevaliez, Stéphane, Soulier, Alexandre, Hézode, Christophe, Wajcman, Henri, Bartels, Doug J., Zhou, Yi, Ardzinski, Andrzej, Mani, Nagraj, Rao, B. Govinda, George, Shelley, Kwong, Ann, Pawlotsky, Jean-Michel
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2010
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2876365/
https://ncbi.nlm.nih.gov/pubmed/20368394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01796-09
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars